Jones C, Courtney J M, Robertson L M, Biggs M S, Lowe G D
Bioengineering Unit, University of Strathclyde, U.K.
Int J Artif Organs. 1989 Jul;12(7):466-70.
The most widely used plasticiser for poly(vinyl chloride) (PVC) is di-(2-ethyl-hexyl) phthalate (DEHP), which is extracted in contact with blood. One approach to reducing plasticiser extraction is to incorporate the higher molecular weight plasticisers trioctyl trimellitate (TOTM) and polymeric adipate (PA). This investigation has compared the influence of these plasticisers with that of DEHP on platelet adhesion and platelet aggregate formation. PVC tubing was tested in the absence of anticoagulants and in the presence of heparin. Our results demonstrate the influence of plasticisers on platelet response and support the view that evaluation of such plasticisers should be extended from an examination of toxicological properties to a comprehensive blood compatibility assessment.
聚氯乙烯(PVC)最常用的增塑剂是邻苯二甲酸二(2-乙基己基)酯(DEHP),它会在与血液接触时被析出。减少增塑剂析出的一种方法是加入分子量更高的增塑剂偏苯三酸三辛酯(TOTM)和聚己二酸酯(PA)。本研究比较了这些增塑剂与DEHP对血小板黏附和血小板聚集体形成的影响。在无抗凝剂和有肝素存在的情况下对PVC管材进行了测试。我们的结果证明了增塑剂对血小板反应的影响,并支持这样一种观点,即对此类增塑剂的评估应从毒理学特性检查扩展到全面的血液相容性评估。